Clinical Trials Detalhe
A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis
General Information
Gender
ALL
Age
N/A
Phase
PHASE3
Study Type
INTERVENTIONAL
Location
Porto, Portugal
Clinicaltrial.gov
https://classic.clinicaltrials.gov/ct2/show/NCT00876447Summary
The purpose of this study is to assess the long-term safety and effectiveness of botulinum toxin type A on patients with overactive bladder as a result of spinal cord injury or multiple sclerosis. This is a follow-up study to two Allergan sponsored studies (NCT00311376 and NCT00461292).
Conditions
Overactive Bladder
Eligibility
Inclusion Criteria: * Patient has participated in study 191622-515 or 191622-516 and the following criteria fulfilled: * Patient completed at least 52 weeks in the preceding study. * No longer than 6 months has elapsed since completion of the preceding study * Patient has not received any prohibited medications during any intervening period between the preceding study and this long-term study. Exclusion Criteria: * History or evidence of pelvic or urologic abnormality. * Previous or current diagnosis of bladder or prostate cancer.